Free fatty acid receptor

Free fatty acid receptors (FFARs) are G-protein coupled receptors (GPRs).[1] GPRs (also termed seven-(pass)-transmembrane domain receptors) are a large protein family of receptors. They reside on their parent cells' surface membranes, bind any one of a specific set of ligands that they recognize, and thereby are activated to elicit certain types of responses in their parent cells.[2] Humans have >800 different types of GPCR receptors.[3] The FFARs are GPCR receptors that bind and thereby are activated by particular fatty acids. In general, these binding/activating fatty acids are straight-chain fatty acids consisting of a carboxylic acid residue, i.e., -COOH, attached to aliphatic chains, i.e. carbon atom chains of varying lengths and bound to 1, 2 or 3 hydrogens (CH1, CH2, or CH3).[4] For example, propionic acid is short-chain fatty acid consisting of 3 carbons (C's), CH3-CH2-COOH, and docosahexaenoic acid is long chain polyunsaturated fatty acid consisting of 22 C's and six double bonds (notated as "="): CH3-CH2-CH1=CH1-CH2-CH1=CH1-CH2-CH1=CH1-CH2-CH1=CH1-CH2-CH1=CH1-CH2-CH1=CH1-CH2-CH2-COOH.

free fatty acid receptor 1
Identifiers
SymbolFFAR1, FFA1R
Alt. symbolsGPR40
NCBI gene2864
HGNC4498
OMIM603820
RefSeqNM_005303
UniProtO14842
Other data
LocusChr. 19 q13.1
Search for
StructuresSwiss-model
DomainsInterPro
free fatty acid receptor 2
Identifiers
SymbolFFAR2
Alt. symbolsGPR43, FFA2R
NCBI gene2867
HGNC4501
OMIM603823
RefSeqNM_005306
UniProtO15552
Other data
LocusChr. 19 q13.1
Search for
StructuresSwiss-model
DomainsInterPro
free fatty acid receptor 3
Identifiers
SymbolFFAR3
Alt. symbolsGPR41, FFA3R
NCBI gene2865
HGNC4499
OMIM603821
RefSeqNM_005304
UniProtO14843
Other data
LocusChr. 19 q13.1
Search for
StructuresSwiss-model
DomainsInterPro
G protein-coupled receptor 42
Identifiers
SymbolGPR42
Alt. symbolsGPR41L, FFAR1L
NCBI gene2866
HGNC4500
OMIM603822
RefSeqNM_005305
UniProtO15529
Other data
LocusChr. 19 q31.1
Search for
StructuresSwiss-model
DomainsInterPro

Currently, four FFARs are recognized: FFAR1, also termed GPR40; FFAR2, also termed GPR43; FFAR3, also termed GPR41; and FFAR4, also termed GPR120.[5] The human FFAR1, FFAR2,, and FFAR3 genes are located adjacent to each other on the long (i.e., "q") arm of chromosome 19 at position 23.33 (notated as 19q23.33). This location also includes the GPR42 gene which appears to be a segmental duplication of the FFAR3 gene; it encodes proteins with a FFAR3-like structure but their activities and functions have not yet been clearly defined.[6][7][8] The human FFAR1 gene is located on the arm long (i.e. "q") arm of chromosome 10 (notated as 10q23.33).[9] FFAR2 and FFAR3 bind and are activated by short-chain fatty acids, i.e., fatty acid chains consisting of 6 or less carbon atoms such as acetic, butyric, and propionic acids.[10] FFAR1 and FFAR4 bind to and are activated by medium-chain fatty acids (i.e. fatty acids consisting of 6-12 carbon atoms such as lauric acid[11]) as well as long-chain unsaturated fatty acids such as palmitic acid, monounsaturated fatty acids such as oleic acid, and polyunsaturated fatty acids such as linoleic, alpha-linolenic, eicosapentaenoic, and docosahexaenoic acids.[4]

Based on its binding and activation by medium-chain fatty acids i.e., capric acid, undecaenoic, and lauric acids,[12] GPR84 has been recognized as possible member of the free fatty acid receptor family.[13] However, GPR84 has not yet been given a FFAR designation possibly because capric acid, the most potent medium-chain fatty acid in activating GPR44, nonetheless requires high concentrations (e.g., in the micromolar range) to do so.[14]

GPR109A (also termed hydroxycarboxylic acid receptor 22, niacin receptor 1, HM74a, HM74b, or PUMA-G),[15] GPR91 (also termed the succinic acid receptor or SUCNR1), and GPR35 have been grouped with FFARs by some authors.[16] However, these receptors are more often defined as receptors primarily for non-straight-chain fatty acid ligands or physiological agents that are not fatty acids. GP109A binds and is activated by niacin, beta-hydroxybutyric acid, and butyric acid; it is often termed a hydroxycarboxylic acid receptor.[15] GPA91 binds and is activated by succinic acid.[3] And, GPR35, which remains classified as an orphan receptor (i.e., a receptor whose ligand(s) are not clearly identified) binds and is activated by a metabolite of tryptophan viz., kynurenic acid,[17] as well as by 5-hydroxyindoleacetic acid (a metabolite of serotonin) and various other small non-fatty acid molecules such as lysophosphatidic acid.[18] 5-Hydroxyindolacetic acid is a particularly potent activator of GPR35 and may be the most important of its naturally occurring activators.[18]

References

  1. Covington DK, Briscoe CA, Brown AJ, Jayawickreme CK (2006). "The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing". Biochem. Soc. Trans. 34 (Pt 5): 770–3. doi:10.1042/BST0340770. PMID 17052194.
  2. Weis WI, Kobilka BK (June 2018). "The Molecular Basis of G Protein-Coupled Receptor Activation". Annual Review of Biochemistry. 87: 897–919. doi:10.1146/annurev-biochem-060614-033910. PMC 6535337. PMID 29925258.
  3. Liang C, Li J, Tian B, Tian L, Liu Y, Li J, Xin L, Wang J, Fu C, Shi Z, Xia J, Liang Y, Wang K (December 2021). "Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment". Biomedicine & Pharmacotherapy. 144: 112298. doi:10.1016/j.biopha.2021.112298. PMID 34649219. S2CID 238990829.
  4. Karmokar PF, Moniri NH (December 2022). "Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells". Biochemical Pharmacology. 206: 115328. doi:10.1016/j.bcp.2022.115328. PMID 36309079. S2CID 253174629.
  5. Frei R, Nordlohne J, Hüser U, Hild S, Schmidt J, Eitner F, Grundmann M (April 2021). "Allosteric targeting of the FFA2 receptor (GPR43) restores responsiveness of desensitized human neutrophils". Journal of Leukocyte Biology. 109 (4): 741–751. doi:10.1002/JLB.2A0720-432R. PMC 8048482. PMID 32803826.
  6. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ (March 2003). "The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids". The Journal of Biological Chemistry. 278 (13): 11312–9. doi:10.1074/jbc.M211609200. PMID 12496283.
  7. Liaw CW, Connolly DT (November 2009). "Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42". DNA and Cell Biology. 28 (11): 555–60. doi:10.1089/dna.2009.0916. PMID 19630535.
  8. Puhl HL, Won YJ, Lu VB, Ikeda SR (August 2015). "Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed". Scientific Reports. 5: 12880. Bibcode:2015NatSR...512880P. doi:10.1038/srep12880. PMC 4531286. PMID 26260360.
  9. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Körner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Lévy-Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P (February 2012). "Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human". Nature. 483 (7389): 350–4. doi:10.1038/nature10798. hdl:2433/153278. PMID 22343897.
  10. Ang Z, Xiong D, Wu M, Ding JL (January 2018). "FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing". FASEB Journal. 32 (1): 289–303. doi:10.1096/fj.201700252RR. PMC 5731126. PMID 28883043.
  11. Christiansen E, Hudson BD, Hansen AH, Milligan G, Ulven T (May 2016). "Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer" (PDF). Journal of Medicinal Chemistry. 59 (10): 4849–58. doi:10.1021/acs.jmedchem.6b00202. PMID 27074625.
  12. Wang J, Wu X, Simonavicius N, Tian H, Ling L (November 2006). "Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84". The Journal of Biological Chemistry. 281 (45): 34457–64. doi:10.1074/jbc.M608019200. PMID 16966319.
  13. Falomir-Lockhart LJ, Cavazzutti GF, Giménez E, Toscani AM (2019). "Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors". Frontiers in Cellular Neuroscience. 13: 162. doi:10.3389/fncel.2019.00162. PMC 6491900. PMID 31105530.
  14. Luscombe VB, Lucy D, Bataille CJ, Russell AJ, Greaves DR (November 2020). "20 Years an Orphan: Is GPR84 a Plausible Medium-Chain Fatty Acid-Sensing Receptor?". DNA and Cell Biology. 39 (11): 1926–1937. doi:10.1089/dna.2020.5846. PMID 33001759. S2CID 222168213.
  15. Taing K, Chen L, Weng HR (April 2023). "Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain". Neural Regeneration Research. 18 (4): 763–768. doi:10.4103/1673-5374.354514. PMC 9700108. PMID 36204834.
  16. Duah M, Zhang K, Liang Y, Ayarick VA, Xu K, Pan B (February 2023). "Immune regulation of poly unsaturated fatty acids and free fatty acid receptor 4". The Journal of Nutritional Biochemistry. 112: 109222. doi:10.1016/j.jnutbio.2022.109222. PMID 36402250. S2CID 253652038.
  17. Milligan G (May 2023). "GPR35: from enigma to therapeutic target". Trends in Pharmacological Sciences. 44 (5): 263–273. doi:10.1016/j.tips.2023.03.001. PMID 37002007. S2CID 257865854.
  18. De Giovanni M, Chen H, Li X, Cyster JG (March 2023). "GPR35 and mediators from platelets and mast cells in neutrophil migration and inflammation". Immunological Reviews. doi:10.1111/imr.13194. PMID 36928841. S2CID 257584110.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.